Related Experiment Video
Updated: Aug 13, 2025
11:30
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
24.0K
Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine
Ikuma Hori1, Hideyoshi Harashima1, Yuma Yamada1
1Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
International Journal of Molecular Sciences
|January 21, 2023
Summary
Researchers developed a novel "MITO-Porter" lipid nanoparticle to deliver berberine (BBR) directly to mitochondria. This enhanced delivery improved cellular energy production and mitochondrial function, offering a promising strategy for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Pharmacology
Background:
- Mitochondria are crucial for neuronal energy production, making them therapeutic targets for neurodegenerative diseases.
- Berberine (BBR) exhibits potential for neurodegenerative diseases due to its effects on mitochondrial metabolism.
- Efficient delivery of BBR to mitochondria remains a challenge.
Purpose of the Study:
- To develop a novel mitochondrial drug delivery system for Berberine (BBR).
- To evaluate the efficacy of BBR delivered via a "MITO-Porter" lipid nanoparticle (LNP) in Neuro2a cells.
- To investigate the impact of enhanced mitochondrial BBR delivery on cellular metabolism and mitochondrial function.
Main Methods:
- Preparation of a lipid nanoparticle (LNP) system, termed "MITO-Porter", encapsulating Berberine (BBR).
- Treatment of Neuro2a cells with MITO-Porter (BBR) and naked BBR.
- Quantification of BBR accumulation in mitochondria.
- Measurement of ATP production levels.
- Assessment of mitochondrial ubiquitin ligase (MITOL) expression.
Main Results:
- MITO-Porter (BBR) significantly increased BBR accumulation within mitochondria compared to naked BBR.
- Treatment with MITO-Porter (BBR) led to enhanced ATP production in Neuro2a cells.
- MITO-Porter (BBR) treatment increased the expression of mitochondrial ubiquitin ligase (MITOL), indicating improved mitochondrial quality control.
Conclusions:
- Enhanced mitochondrial delivery of BBR via the MITO-Porter system potentiates its pharmacological effects.
- This LNP-based delivery approach is crucial for regulating mitochondrial metabolic mechanisms in nerve cells.
- The MITO-Porter system shows significant potential for therapeutic applications in neurodegenerative diseases.
